Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $241,368 - $331,464
1,323 New
1,323 $260,000
Q2 2022

Aug 15, 2022

SELL
$204.13 - $302.4 $214,336 - $317,520
-1,050 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $268,285 - $380,215
1,050 New
1,050 $298,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Credit Capital Investments LLC Portfolio

Follow Credit Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Credit Capital Investments LLC with notifications on news.